EMS Stocks Crack Up To 8% In 2 Days, Hit 52-Week Lows

The shares of major EMS firms, such as Dixon Technologies and Kaynes Technology, continued to fall further, slipping for the second straight day on Wednesday, going as low as 8%, making new 52-week lows.

The market data revealed a strong sector correction with Kaynes Technology declining intraday by 3% at ₹3,682.15 and Dixon Technologies declining 2% at ₹11,480. The reason for this fall is that the overall market is consolidating with the BSE Sensex slightly declining.

Invest in Indian Markets and Unlock Future Potential With 5paisa!

Open Account Now

Sharp Valuation Correction

The decline, however, points to a significant hit to the value for these erstwhile hot stocks. Kaynes Technology is technically down by about 52% from its 52-week high price of ₹7,705, which was recorded on October 7, 2025. Dixon Technology is down by about 38% from its high of ₹18,549.35, which was recorded a year ago. Investors appear to be factoring in a tougher outlook in the coming period, where they move away from high-growth stocks that were highly valued in a manner that reflected the electronics boom that occurred in the aftermath of the pandemic. 

Regulatory and Margin Headwinds

Dixon Technologies is affected by the holdups in some critical government approval clearances. As per news reports, the company is still awaiting PN3 approval for its joint ventures with the Vivo and HKC brands. Initially, the approval dates for these were in November 2025, which have been pushed only in this month. Even the company's volumes and margins in FY 2027 will be endangered due to this uncertainty.

Furthermore, a rise in memory costs also contributes to increasing expenses for budget models, forcing certain companies to let go of their market share. This could negatively affect production volumes for contract manufacturers.
     
On a related front, companies such as CLSA indicate that while the government intends to extend norms for importation of IT hardware until December 2026, it would reduce the current pressure on certain brands, including Lenovo as well as HP, to localise their manufacturing, which would affect Dixon’s order book.
Capital Intensity Weighs on Kaynes

While Kaynes Technology is striving for growth, cash generation remains under full investor scrutiny. Rating agencies have pointed out that despite a strong order book, operating cash flows have remained negative due to rapid expansion and high working capital requirements typical of the ESDM sector.

It has outlined a large capex plan of ₹4,700 crore over the next five years. This ambitious expansion includes entry into outsourced semiconductor assembly and testing, or OSAT, which is expected to commence from Q4 FY26. The expansion is heavily dependent on government subsidies and proceeds from the recent QIP issue. Subsidies being sanctioned in time are now keenly awaited by investors to ensure that leverage remains decent for the company.